Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Carbinoxamine maleate salt
Cat. No.:
OB0225LY-0104
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Carbinoxamine maleate salt is an antihistamine that is effective in reducing allergic reactions by counteracting H1 receptors.
Synonym:
Lergefin; 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine maleate; Ethanamine, 2-((4-chlorophenyl)-2-pyridinylmethoxy)-N, N-dimethyl-, (Z)-2-butenedioate (1:1); 2-((4-Chlorophenyl)(pyridin-2-yl)methoxy)-N, N-dimethylethan-1-amine maleate; Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)-, maleate (1:1)
CAS No.:
3505-38-2
Compound CID:
5282409
Formula:
C20H23ClN2O5
Formula Weight:
406.86
Specification
Relative Density:
1.079 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Carbinoxamine maleate salt can be used to relieve allergy symptoms, including rhinitis, conjunctivitis and skin allergic reactions.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
Neuronal signaling; Immunology/Inflammation; GPCR/G protein
Plate Number:
AOCL-2
Plate Location:
c7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 135.18 mM
Ethanol Max Solubility:
81 mg/mL; 199.09 mM
